Study Comparing Home-Based Upper Limb Rehabilitation Using the Neofect Smart Board Versus Conventional Therapy in Adults With Brain Disorders

What this Trial Is About

Researchers are evaluating the clinical effectiveness, ease of use, and safety of a home-based upper limb rehabilitation program using the Neofect Smart Board. The study compares this approach to traditional home-based occupational therapy in patients with upper limb dysfunction due to neurological diseases in the late subacute and chronic stages. Participants include adults aged 19 to 85 who have hemiparesis from conditions like stroke, traumatic brain injury, or brain tumor, lasting more than three months. The trial has two groups one uses the Neofect Smart Board device for rehabilitation, and the other uses a workbook provided by the research team for occupational therapy. Both groups complete 20 sessions, each lasting 30 minutes, with one session per day, five days a week, over four weeks. The study is randomized and single-blinded to compare the two rehabilitation methods fairly. Participants will be assessed on their upper limb function using the Fugl-Meyer assessment before and after the intervention. Researchers will monitor muscle strength, spasticity, cognitive function, and ability to perform tasks. Safety and usability of the device will also be observed. The total participation time includes the four-week training period with assessments conducted within two days after the intervention and up to 14 days before it.

Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder